Expected earnings - aTyr Pharma Inc.
Source: US Earnings Reports
aTyr Pharma Inc. (ATYR) is expected to report $-0.18 for Q4 2025
aTyr Pharma Inc.
NASDAQ: ATYR
ATYR Trading
10.62% G/L:
$0.9372 Last:
612,510 Volume:
$0.904 Open:
ATYR Latest News
March 05, 2026 04:01:00 pm
aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update
February 03, 2026 08:00:00 am
aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis
ATYR Stock Data
$86,228,238
94,145,558
1.44%
38
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
